Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xilio Therapeutics (XLO) Non-cash Items (2024 - 2025)

Historic Non-cash Items for Xilio Therapeutics (XLO) over the last 2 years, with Q3 2025 value amounting to $6.5 million.

  • Xilio Therapeutics' Non-cash Items rose 641851.41% to $6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.5 million, marking a year-over-year increase of 641851.41%. This contributed to the annual value of $282000.0 for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Xilio Therapeutics' Non-cash Items is $6.5 million, which was up 641851.41% from $39000.0 recorded in Q2 2025.
  • In the past 5 years, Xilio Therapeutics' Non-cash Items ranged from a high of $6.5 million in Q3 2025 and a low of $39000.0 during Q2 2025